{{Rsnum
|rsid=3814231
|Gene=CASP7
|Chromosome=10
|position=115481018
|Orientation=minus
|GMAF=0.2718
|Gene_s=CASP7
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=135
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 8.0 | 40.7 | 51.3
| HCB | 14.6 | 54.0 | 31.4
| JPT | 21.2 | 54.0 | 24.8
| YRI | 2.1 | 18.5 | 79.5
| ASW | 0.0 | 15.8 | 84.2
| CHB | 14.6 | 54.0 | 31.4
| CHD | 19.4 | 49.1 | 31.5
| GIH | 5.0 | 41.0 | 54.0
| LWK | 0.9 | 24.8 | 74.3
| MEX | 12.1 | 39.7 | 48.3
| MKK | 3.2 | 28.2 | 68.6
| TSI | 5.9 | 36.3 | 57.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=22548721
|Title=Association between CASP7 and CASP14 genetic polymorphisms and the risk of childhood leukemia
}}
{{PMID Auto GWAS
|PMID=22561518
|Trait=None
|Title=Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo.
|RiskAllele=G
|Pval=4E-8
|OR=1.2300
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}